Inducing and Administering Tregs to Treat Human DiseaseKey role of the GITR/GITRLigand pathway in the development of murine autoimmune diabetes: a potential therapeutic targetA view on beta cell transplantation in diabetes.IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cellsImmune therapy for type 1 diabetes mellitus-what is unique about anti-CD3 antibodies?Recent lessons learned from prevention and recent-onset type 1 diabetes immunotherapy trials.Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.CD3-specific antibodies: a portal to the treatment of autoimmunity.The use of monoclonal antibodies to restore self-tolerance in established autoimmunity.Chemical immunosuppression in islet transplantation--friend or foe?Diversity of regulatory CD4+T cells controlling distinct organ-specific autoimmune diseasesImmunoregulatory pathways controlling progression of autoimmunity in NOD mice.Therapeutic use of a selective S1P1 receptor modulator ponesimod in autoimmune diabetesCD3-specific antibody-induced active tolerance: from bench to bedside.CD3 antibody treatment stimulates the functional capability of regulatory T cells.Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes.Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.Anti-CD3 antibodies: towards clinical antigen-specific immunomodulation.Monoclonal antibody-based strategies in autoimmunity and transplantation.ZnT8 is a major CD8+ T cell-recognized autoantigen in pediatric type 1 diabetes.Regulatory T cells in the control of autoimmune diabetes: the case of the NOD mouse.Resetting the functional capacity of regulatory T cells: a novel immunotherapeutic strategy to promote immune tolerance.CD3-specific antibodies restore self-tolerance: mechanisms and clinical applications.CD3-specific antibodies as promising tools to aim at immune tolerance in the clinic.In vivo activation of transferred regulatory T cells specific for third-party exogenous antigen controls GVH disease in mice.Transforming growth factor-beta and T-cell-mediated immunoregulation in the control of autoimmune diabetes.TGFβ-dependent expression of PD-1 and PD-L1 controls CD8(+) T cell anergy in transplant toleranceProtection from autoimmunity: immunological indifference versus T-cell mediated suppression?Immune therapies of autoimmune diseases: are we approaching a real cure?The anti-CD3-induced syndrome: a consequence of massive in vivo cell activation.Delayed anti-CD3 therapy results in depletion of alloreactive T cells and the dominance of Foxp3+ CD4+ graft infiltrating cells.CD3 antibodies as unique tools to restore self-tolerance in established autoimmunity their mode of action and clinical application in type 1 diabetes.Progress towards the clinical use of CD3 monoclonal antibodies in the treatment of autoimmunity.Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: immune therapies of type 1 diabetes: new opportunities based on the hygiene hypothesis.New generation CD3 monoclonal antibodies: are we ready to have them back in clinical transplantation?A historical view from thirty eventful years of immunotherapy in autoimmune diabetes.Harnessing regulatory T cells for transplant tolerance in the clinic through mTOR inhibition: myth or reality?Clinical immunologic interventions for the treatment of type 1 diabetes.Anti-CD3 clinical trials in type 1 diabetes mellitus.
P50
Q26772723-D970D5E8-2BA7-47A8-8923-76E552AA0E75Q28750209-5E670DB4-ABFF-43F7-98C0-5CEE10414407Q33183714-B0065225-8816-4EEE-974F-8576AD812FCEQ34096577-FF664C3F-F07C-4437-8E6C-3946CCE05319Q34099969-146BAC25-0517-4E5F-926B-9F836FC11F02Q34318993-2E0D7539-16E0-4366-9BFC-F17BD99C3769Q34428346-715EFEDB-A597-4DB7-A933-C9651D67FB1AQ34654024-99D289F6-62BE-486B-A53D-11B937300DD8Q34715485-4B45EE34-6CF8-4ED5-9249-8D0A0AD232B6Q34761298-A1615DF2-5FE0-4222-946A-3D606C845402Q34791870-950AC6B8-AD46-4897-924E-9AA994337E23Q34920085-138426D3-6E44-45EA-92FB-9C2ED7055F4AQ35035148-C692C193-7D5C-482A-8CA9-AAD8EA7709C9Q35058543-AD1DE8DD-1121-4785-BE41-5A9EB57E95FEQ35580439-A8159D33-6B1C-463C-BF73-F96653C0EB02Q35603139-42BF137E-4948-44CE-B201-5567419DD260Q35748567-003F60BE-F317-4E57-AA49-1017188ACE8EQ35834935-84597450-A42C-44D9-B93A-B5263132C674Q35977056-D3335EC8-D29A-495A-84DB-B5DAAEEC81B6Q36047531-74090CAD-46A2-4C8E-AAAE-756BE80CE8BEQ36203572-C0708E9A-D2A7-4F9D-ABFC-F5EEC28165E4Q36269628-579EB83C-2644-4303-9D11-0CEC023CF85FQ36281370-5D665AF2-82DB-416D-A43E-AEFFCD1D52DEQ36526356-8AE433D5-E612-4508-B6E9-7DFCB39448E2Q36537036-D9BCCE01-CD40-43F0-9E85-64B4452BC1A0Q36563528-3C548427-DFD9-492C-A84F-1ECC7BF58ABBQ36568502-E24B6964-5091-40FA-8129-6CC22CA94808Q36585235-8AB58C78-600D-4986-901B-A33241AAED34Q36608576-A1D3AEC1-69D3-4DB5-83F6-CEA5DB91BEE7Q37130564-230D3743-DFBC-4B93-9AA1-B219E63AB6B1Q37216199-83088D21-42AA-4D67-AF95-71ECF6AA6E2CQ37358990-8E9EAC02-A6D2-4FDE-B0AA-516F4FC02D5FQ37554213-1A9A3960-E521-4429-AEA8-B56D01E8EF61Q37569990-F64D96E6-6213-4615-A353-1AA373AD774DQ37736589-7FECCDE3-0E57-406B-B1C7-CB1304E5B728Q37794622-58E49BBF-194A-4F7B-AA93-A88B50CD7F7BQ37918656-22456DA6-3930-4A59-B592-192066DFA487Q37942449-9766890D-8E8A-4C02-B246-D6395729A8FCQ38036230-6A740F72-DB91-42EB-BF79-37567AAA50FEQ38111027-E481FDD0-369C-4EF0-A2AD-425D39AE7DE5
P50
description
Frans professor
@nl
French professor
@en
catedràtica francesa
@ca
catedrática francesa
@es
französische Immunologin
@de
katedradun frantziarra
@eu
profesora francesa
@ast
profesora francesa
@gl
professeure française
@fr
professora francesa
@pt
name
Lucienne Chatenoud
@ast
Lucienne Chatenoud
@ca
Lucienne Chatenoud
@de
Lucienne Chatenoud
@en
Lucienne Chatenoud
@es
Lucienne Chatenoud
@fr
Lucienne Chatenoud
@it
Lucienne Chatenoud
@nl
Lucienne Chatenoud
@sl
Lucienne Chatenoud
@sq
type
label
Lucienne Chatenoud
@ast
Lucienne Chatenoud
@ca
Lucienne Chatenoud
@de
Lucienne Chatenoud
@en
Lucienne Chatenoud
@es
Lucienne Chatenoud
@fr
Lucienne Chatenoud
@it
Lucienne Chatenoud
@nl
Lucienne Chatenoud
@sl
Lucienne Chatenoud
@sq
prefLabel
Lucienne Chatenoud
@ast
Lucienne Chatenoud
@ca
Lucienne Chatenoud
@de
Lucienne Chatenoud
@en
Lucienne Chatenoud
@es
Lucienne Chatenoud
@fr
Lucienne Chatenoud
@it
Lucienne Chatenoud
@nl
Lucienne Chatenoud
@sl
Lucienne Chatenoud
@sq
P214
P227
P244
P268
P269
P106
P19
P21
P213
0000 0000 8377 2276
P214
P227
P244
P268
P269
P27
P2798
P31
P569
1956-08-15T00:00:00Z
P735
P7859
lccn-n95801984